Caleb Alexander, M.D., M.S.
Co-Director, Center for Drug Safety and Effectiveness, Bloomberg School of Public Health, Johns Hopkins
Dr. Alexander is a practicing general internist and pharmacoepidemiologist who is nationally renowned for his work examining prescription drug utilization. He is an Associate Professor in the Departments of Epidemiology and Medicine and co-Director of the Johns Hopkins Center for Drug Safety and Effectiveness. His work focuses on population-based patterns and determinants of pharmaceutical use, clinical decision-making regarding prescription drugs, and the impact of changes in regulatory and payment policy on pharmaceutical utilization. In addition to expertise conducting survey-based investigations, Dr. Alexander has also extensive experience with the analysis of secondary data sources including administrative claims, the Medical Expenditure Panel Survey and the National Ambulatory Medical Care Survey. Dr. Alexander is the author of more than one hundred peer-reviewed publications and is an ad hoc member of the FDA Drug Safety and Risk Management Advisory Committee. He is currently the Principal or Co-Principal Investigator of RO1s from the AHRQ and the NHLBI that examine the effect of FDA regulatory communications and direct-to-consumer advertising on prescription and non-prescription health care utilization.